» Articles » PMID: 27893210

Impact of Treatment Type on Overall Survival in ElderlyBrazilian Women with Breast Cancer

Abstract

Objective: To analyze the survival of elderly patients with breast cancer according to the type of treatment used. Methods: A cohort study of women aged 80 or over with breast cancer registered with the Brazilian National Cancer Institute (Instituto Nacional do Câncer - INCA) between 2008 and 2009 was conducted. Prognosis was analyzed according to the cancer treatment performed: surgery, radiotherapy, or hormone therapy. Analysis of the overall 5-year survival rate was performed using the Kaplan - Meier method, and comparisons of curves were undertaken using the log-rank test. For multiple regression analysis, Cox regression was used, adjusting for age and clinical stage, considering values of p < 0.05 as significant. Data were all analyzed using the statistical package SPSS version 20. Results: 70 women with a mean age of 84.0 ± 3.7 years at diagnosis participated in the study. The median follow-up time was 37.1 months (range 0.5–75.5), and 31 deaths (44.3%) occurred during this time. The median survival time was 51.2 months (95% CI, 44.9–57.4), higher in those who underwent surgery (p = 0.012) and those who had hormone therapy (p=0.001). Treatment with surgery reduced the risk of death by 61.7% (HR 0.3; 95% CI, 0.1–0.6; p = 0.001) when adjusted for clinical stage and age at diagnosis. However, there was no significant benefit from radiotherapy (HR 1.2; 95% CI, 0.5–2.5; p = 0.694). Conclusion: Treatment with surgery and hormone therapy increased the survival of our Brazilian patients with breast cancer aged 80 or over.

Citing Articles

Temporal Trends in the Completeness of Epidemiological Variables in a Hospital-Based Cancer Registry of a Pediatric Oncology Center in Brazil.

Grassi J, Pessanha R, Grippa W, DellAntonio L, DellAntonio C, Faure L Int J Environ Res Public Health. 2024; 21(2).

PMID: 38397690 PMC: 10888061. DOI: 10.3390/ijerph21020200.


Geriatric Breast Cancer: Staging, Molecular Surrogates, and Treatment. A Review & Meta-analysis.

Fonseca V, Sidiropoulou Z Aging Dis. 2023; 15(4):1602-1618.

PMID: 37962462 PMC: 11272193. DOI: 10.14336/AD.2023.1002.


Incompleteness trends of epidemiological variables in a Brazilian high complexity cancer registry: An ecological time series study.

Grippa W, DellAntonio L, Salaroli L, Lopes-Junior L Medicine (Baltimore). 2023; 102(31):e34369.

PMID: 37543818 PMC: 10402934. DOI: 10.1097/MD.0000000000034369.


Survival Time and Prognostic Factors for Breast Cancer among Women in North-East Peninsular Malaysia.

Nordin N, Yaacob N, Abdullah N, Mohd Hairon S Asian Pac J Cancer Prev. 2018; 19(2):497-502.

PMID: 29480991 PMC: 5980940. DOI: 10.22034/APJCP.2018.19.2.497.

References
1.
Sierink J, de Castro S, Russell N, Geenen M, Steller E, Vrouenraets B . Treatment strategies in elderly breast cancer patients: Is there a need for surgery?. Breast. 2014; 23(6):793-8. DOI: 10.1016/j.breast.2014.08.006. View

2.
Louwman W, Janssen-Heijnen M, Houterman S, Voogd A, van der Sangen M, Nieuwenhuijzen G . Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer. 2005; 41(5):779-85. DOI: 10.1016/j.ejca.2004.12.025. View

3.
Sanguinetti A, Polistena A, Lucchini R, Monacelli M, Avenia S, Conti C . Breast cancer in older women: what factors affect the treatment?. Int J Surg. 2014; 12 Suppl 2:S177-S180. DOI: 10.1016/j.ijsu.2014.08.346. View

4.
Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P . Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol. 2003; 21(19):3580-7. DOI: 10.1200/JCO.2003.02.046. View

5.
Naito Y, Mukai H, Nagai S . Elderly breast cancer therapy: a Japanese experience. Jpn J Clin Oncol. 2010; 40(8):717-21. DOI: 10.1093/jjco/hyq061. View